Drugs / Autologous CD34+ cells transduced with WASP lentiviral vector
Autologous CD34+ cells transduced with WASP lentiviral vector
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02333760 | Sep 2014 → Oct 2032 expected | Wiskott-Aldrich syndrome | Genethon | Active not recruiting | Met primary |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Autologous CD34+ cells transduced with WASP lentiviral vector | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02333760 ↗ |